Sartorius expands biopharma manufacturing in Slovenia
Sartorius plans to expand production facilities for purification products for vaccines and therapies at its facility in Ajdovscina, Slovenia. Read More
Humanigen seeks FDA approval for COVID-19 drug
Humanigen requested an emergency use authorization from the U.S. Food and Drug Administration (FDA) to use its drug lenzilumab in hospitalized COVID-19 patients. Read More
August Bioservices raises $24M to grow U.S. manufacturing
August Bioservices has raised about $24 million in funding to expand its biomanufacturing capabilities in the U.S. Read More
TetraScience releases latest R&D data platform
TetraScience announced that the latest version of its Tetra Data Platform now includes bidirectional data integration capabilities for fully traceable, round trip automation between lab instruments and electronic laboratory notebooks/laboratory information management systems. Read More
Scientist.com debuts pre-assessment program for new suppliers
Scientist.com announced the launch of the company's pre-assessment program for new suppliers. Read More
ONK obtains license for NK cells for cancer treatment
ONK Therapeutics announced it inked a patent license deal with Australia's Walter and Eliza Hall Institute of Medical Research for rights to CISH knockout natural killer (NK) cells for cancer research. Read More
NORD appoints chief medical and scientific officer
The National Organization for Rare Disorders (NORD) has appointed Dr. Edward Neilan, PhD, to the new position of chief medical and scientific officer. Read More
Agilent reports revenue increase for Q2
Agilent Technologies saw revenue exceed expectations for the company's second quarter, while net income more than doubled. Read More
Menarini launches imaged-based cell sorter
Menarini Silicon Biosystems has launched an automated image-based cell sorter featuring nine fluorescent channels. Read More
FDA issues EUA for GSK-Vir COVID-19 mAb treatment
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the investigational monoclonal antibody (mAb) therapy sotrovimab from GlaxoSmithKline (GSK) and Vir Biotechnology. Sotrovimab is a treatment for mild to moderate COVID-19 in adults and pediatric patients over 12 years of age. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
